Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
208 hedge funds and large institutions have $2.15B invested in Immunomedics Inc in 2019 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 80 increasing their positions, 58 reducing their positions, and 25 closing their positions.
225% more call options, than puts
Call options by funds: $79.4M | Put options by funds: $24.4M
38% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 58
24% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 25
2% more funds holding
Funds holding: 204 → 208 (+4)
10% less capital invested
Capital invested by funds: $2.38B → $2.15B (-$233M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$13.6M |
| 2 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$12.7M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$8.25M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$7.97M |
| 5 |
Alkeon Capital Management
New York
|
+$7.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$83.2M |
| 2 |
DM
Deerfield Management
New York
|
-$26M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$25.2M |
| 4 |
State Street
Boston,
Massachusetts
|
-$23.4M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$19.8M |
IMMU Hedge Fund Activity: Q3 2019 in Review
208 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2019, worth a combined $2.15B — down 9.8% from $2.38B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new IMMU positions and 25 closed out — a net gain of 6 holders — while 80 added to existing stakes and 58 trimmed.
The largest buyer was Menora Mivtachim Holdings, adding an estimated $13.6M. The largest seller was Fidelity Investments, cutting an estimated $83.2M.
- 208 institutional investors held Immunomedics Inc (IMMU) as of Q3 2019, up from 204 in Q2 2019.
- Funds reported $2.15B of Immunomedics Inc stock for Q3 2019, down 9.8% quarter-over-quarter.
- 31 funds opened new Immunomedics Inc positions in Q3 2019 and 25 closed out, a net change of +6 holders.
- The largest Immunomedics Inc buyer in Q3 2019 was Menora Mivtachim Holdings, an estimated $13.6M added.
- The largest Immunomedics Inc seller in Q3 2019 was Fidelity Investments, an estimated $83.2M sold.
Based on aggregated 13F filings for Q3 2019.